Matthew T. David - Chief Financial Officer at CorMedix Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CRMD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew T. David since 12/23/2023

Holdings reported by Matthew T. David for CorMedix Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47.9K $166K $3.47 Jan 12, 2024 Direct
Stock Option (Right to Buy Common Stock) 100K Jan 12, 2024 Direct Common Stock

Transactions reported by Matthew T. David for CorMedix Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.